Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 2
2005 3
2006 2
2008 2
2009 6
2010 4
2011 10
2012 8
2013 10
2014 7
2015 6
2016 11
2017 12
2018 7
2019 13
2020 15
2021 24
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
Immunological Aspects of Approved MS Therapeutics.
Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O. Rommer PS, et al. Among authors: warnke c. Front Immunol. 2019 Jul 11;10:1564. doi: 10.3389/fimmu.2019.01564. eCollection 2019. Front Immunol. 2019. PMID: 31354720 Free PMC article. Review.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, Bittner S, Hartung HP, Friese MA, Linker RA, Luessi F, Lehmann-Horn K, Mühlau M, Paul F, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber F, Wildemann B, Zettl UK, Ziemann U, Müller-Myhsok B, Kümpfel T, Klotz L, Meuth SG, Zipp F, Hemmer B, Hohlfeld R, Brassat D, Gold R, Gross CC, Lukas C, Groppa S, Loser K, Wiendl H, Schwab N; German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network. Ostkamp P, et al. Among authors: warnke c. Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2018457118. doi: 10.1073/pnas.2018457118. Proc Natl Acad Sci U S A. 2021. PMID: 33376202 Free PMC article.
[Progressive multifocal leukoencephalopathy].
Warnke C, Wattjes MP, Adams O, Hartung HP, Martin R, Weber T, Stangel M. Warnke C, et al. Nervenarzt. 2016 Dec;87(12):1300-1304. doi: 10.1007/s00115-016-0225-7. Nervenarzt. 2016. PMID: 27730274 Review. German.
[Dysphagia in Multiple Sclerosis - an underestimated symptom?].
Eckardt C, Vay SU, Warnke C, Flossdorf P, Weinert M. Eckardt C, et al. Among authors: warnke c. Fortschr Neurol Psychiatr. 2021 Apr;89(4):168-177. doi: 10.1055/a-1268-8070. Epub 2021 Feb 11. Fortschr Neurol Psychiatr. 2021. PMID: 33571999 Review. German.
Managing Risks with Immune Therapies in Multiple Sclerosis.
Förster M, Küry P, Aktas O, Warnke C, Havla J, Hohlfeld R, Mares J, Hartung HP, Kremer D. Förster M, et al. Among authors: warnke c. Drug Saf. 2019 May;42(5):633-647. doi: 10.1007/s40264-018-0782-8. Drug Saf. 2019. PMID: 30607830 Review.
[Erratum to: Toxicity after chimeric antigen receptor T-cell therapy].
Garcia Borrega J, Heindel K, Göreci Y, Warnke C, Onur OA, Kochanek M, Schub N, Ayuk F, Wichmann D, Böll B. Garcia Borrega J, et al. Among authors: warnke c. Internist (Berl). 2021 Jun;62(6):694. doi: 10.1007/s00108-021-01087-w. Internist (Berl). 2021. PMID: 34115144 German. No abstract available.
Teriflunomide for the treatment of multiple sclerosis.
Warnke C, Stüve O, Kieseier BC. Warnke C, et al. Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S90-4. doi: 10.1016/j.clineuro.2013.09.030. Clin Neurol Neurosurg. 2013. PMID: 24321165 Review.
133 results